Centre for Mathematics, University of Coimbra

Publications

Title
Authors
Publication Year
Scientific Areas
Type

Publications
SUZUKI, Alexandre, (2024). Sturm's comparison theorem for classical discrete orthogonal polynomials. Results in Mathematics. Vol. 79. 4, Article number 153, pp. 1-13.
JESUS, Diogo, HENRIQUES, Carla, MATOS, Ana Cristina, DORIA, Andrea, INÊS, Luis Sousa, (2024). Systemic Lupus Erythematosus Disease Activity Score Remission and Low Disease Activity States Discriminate Drug From Placebo and Better Health-Related Quality of Life. Arthritis Care & Research. Vol. 76. 6, pp. 788-795.
GRIFFITH, Matthew, ARAÚJO, Adérito, TRAVASSO, Rui, SALVADOR, Armindo, (2024). The architecture of redox microdomains: Cascading gradients and peroxiredoxins' redox-oligomeric coupling integrate redox signaling and antioxidant protection. Redox Biology. Vol. 69. Article number 103000, pp. 1-14.
GORDILLO-NÚÑEZ, Guillermo, ALVAREZ-NODARSE, Renato, QUINTERO, Niurka R., (2024). The complete solution of the Schrödinger equation with the Rosen-Morse type potential via the Nikiforov-Uvarov method. Physica D-Nonlinear Phenomena. Vol. 458, pp. 1-12.
COELHO, Catarina, SANTOS, José Luis, JÚDICE, Pedro, (2024). The performance of bank portfolio optimization. International Transactions in Operational Research. Vol. 31, pp. 1-28.
MANUELL, Graham, WRIGLEY, Joshua L., (2024). The representing localic groupoid for a geometric theory. Theory and Applications of Categories - Expositions. Vol. 2024. 2, pp. 1-41.
MANUELL, Graham, (2024). Uniform locales and their constructive aspects. Theory and Applications of Categories. Vol. 41. 8, pp. 238-267.
CARVALHO E SILVA, Jaime, (2024). Uso do Geogebra Book no ensino superior.
HENRIQUES, Carla, (2024). Validation of the SLE-DAS responder index as an accurate and feasible endpoint for SLE clinical trials: A post-hoc study in the phase 2 and 3 ANIFROLUMAB clinical trials.
HENRIQUES, Carla, (2024). Validation of the SLE-DAS responder index as an accurate and feasible endpoint for SLE clinical trials: A post-hoc study in the phase 2 and 3 ANIFROLUMAB clinical trials. Annals of the Rheumatic Diseases. Vol. 83, Supplement 1, pp. 1004-1005.

Number of registers: 4,262<< previous 22,23,24,25,26,27,28,29 next >>